Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Financial results Stock information Press releases and company announcements R&D pipeline Upcoming events

Novo Nordisk Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Latest news

{{'2024-11-06T06:30:49Z' | dateFormatFilter}}

Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024

Read more

{{'2024-11-01T12:13:24Z' | dateFormatFilter}}

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

Read more

{{'2024-10-21T09:26:27Z' | dateFormatFilter}}

Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job openings.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.